MCID: HYP031
MIFTS: 49

Hyperlipoproteinemia Type V malady

Genetic diseases, Rare diseases, Endocrine diseases categories

Summaries for Hyperlipoproteinemia Type V

About this section
Sources:
66Wikipedia, 48OMIM, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 Hyperlipidemia, hyperlipoproteinemia, or hyperlipidaemia (British English) involves abnormally elevated... more...

MalaCards: Hyperlipoproteinemia Type V, also known as familial hyperlipoproteinemia type v, is related to xanthomatosis and tangier disease. An important gene associated with Hyperlipoproteinemia Type V is APOA5 (apolipoprotein A-V), and among its related pathways are PPAR signaling pathway and Diseases associated with visual transduction. The compounds dimyristoylphosphatidylcholine and sele have been mentioned in the context of this disorder. Related mouse phenotype homeostasis/metabolism.

Description from OMIM:48 144650

Aliases & Classifications for Hyperlipoproteinemia Type V

About this section
Sources:
9Disease Ontology, 44NIH Rare Diseases, 23GTR, 48OMIM, 46Novoseek, 50Orphanet, 63UMLS, 59SNOMED-CT, 36MeSH, 60SNOMED-CT via Orphanet, 64UMLS via Orphanet, 37MESH via Orphanet, 27ICD10 via Orphanet
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases, Rare diseases
Anatomical: Endocrine diseases


Aliases & Descriptions:

hyperlipoproteinemia type v 9 44 46 63
familial hyperlipoproteinemia type v 9 23
hyperlipoproteinemia type 5 44 50
hyperchylomicronemia with hyperprebetalipoproteinemia, familial 44
hyperlipemia combined fat and carbohydrate-induced 44
familial type 5 hyperlipoproteinemia 9
hyperchylomicronemia, late-onset 48
hyperchylomicronemia late onset 44
fredrickson type v lipaemia 9
type v hyperlipoproteinemia 44
hyperlipidemia type v 44
major hyperlipidemia 50
mixed hyperlipemia 44
hyperlipemia mixed 44


External Ids:

Disease Ontology9 DOID:1171
OMIM48 144650
SNOMED-CT via Orphanet60 34349009
SNOMED-CT59 34349009, 190781009
UMLS via Orphanet64 C0020481
MESH via Orphanet37 D006954
ICD10 via Orphanet27 E78.3

Related Diseases for Hyperlipoproteinemia Type V

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Graphical network of the top 20 diseases related to Hyperlipoproteinemia Type V:



Diseases related to hyperlipoproteinemia type v

Symptoms for Hyperlipoproteinemia Type V

About this section
Sources:
48OMIM
See all sources

Symptoms by clinical synopsis from OMIM:

144650

Clinical features from OMIM:

144650

Drugs & Therapeutics for Hyperlipoproteinemia Type V

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 63UMLS, 42NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Hyperlipoproteinemia Type V

Drug clinical trials:

Search ClinicalTrials for Hyperlipoproteinemia Type V

Search NIH Clinical Center for Hyperlipoproteinemia Type V

Search CenterWatch for Hyperlipoproteinemia Type V

Genetic Tests for Hyperlipoproteinemia Type V

About this section
Sources:
23GTR
See all sources

Genetic tests related to Hyperlipoproteinemia Type V:

id Genetic test Affiliating Genes
1 Familial Type 5 Hyperlipoproteinemia23

Anatomical Context for Hyperlipoproteinemia Type V

About this section

Animal Models for Hyperlipoproteinemia Type V or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Hyperlipoproteinemia Type V:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053767.9CREB3L3, LPL, APOA5, APOE, GPIHBP1

Publications for Hyperlipoproteinemia Type V

About this section
Sources:
53PubMed
See all sources

Articles related to Hyperlipoproteinemia Type V:

idTitleAuthorsYear
1
Extremity amputation following radial artery cannulation in a patient with hyperlipoproteinemia type V. (7059036)
1982
2
Hyperlipoproteinemia type V and apolipoprotein E4. (6126778)
1982
3
A case of xanthomatosis and hyperlipoproteinemia type V propably induced by overdosage of insulin. (173587)
1975
4
Hyperlipoproteinemia type V: biochemical observations in two cases. (4365209)
1974
5
Hyperlipoproteinemia type V (a case report). (4374435)
1974

Variations for Hyperlipoproteinemia Type V

About this section
Sources:
1 National Center for Biotechnology Information (Clinvar)
See all sources

Clinvar genetic disease variations for Hyperlipoproteinemia Type V:

1
id Gene Name Type Significance SNP ID Assembly Location
1APOA5NM_052968.4(APOA5): c.415C> T (p.Gln139Ter)single nucleotide variantPathogenicrs121917821GRCh37Chr 11, 116661530: 116661530

Expression for genes affiliated with Hyperlipoproteinemia Type V

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Hyperlipoproteinemia Type V

Search GEO for disease gene expression data for Hyperlipoproteinemia Type V.

Pathways for genes affiliated with Hyperlipoproteinemia Type V

About this section
Sources:
51PathCards, 31KEGG, 39NCBI BioSystems Database, 56Reactome, 52PharmGKB
See all sources

Compounds for genes affiliated with Hyperlipoproteinemia Type V

About this section
Sources:
46Novoseek, 25HMDB, 52PharmGKB, 12DrugBank, 62Tocris Bioscience, 30IUPHAR
See all sources

Compounds related to Hyperlipoproteinemia Type V according to GeneCards/GeneDecks:

(show top 50)    (show all 320)
idCompoundScoreTop Affiliating Genes
1dimyristoylphosphatidylcholine4610.0APOE, APOA5
2sele469.9APOE, LPL
3retinyl palmitate46 2510.9LPL, APOE
4intralipid469.9LPL, APOE
5xbai469.9LPL, APOE
6trioleoylglycerol469.6LPL, APOC2
7TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso6]259.6LPL, APOC2
8TG(18:3(9Z,12Z,15Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]259.6APOC2, LPL
9TG(18:3(9Z,12Z,15Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]259.6APOC2, LPL
10TG(18:3(9Z,12Z,15Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]259.6APOC2, LPL
11TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]259.6APOC2, LPL
12TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]259.6APOC2, LPL
13TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))[iso3]259.6APOC2, LPL
14TG(18:2(9Z,12Z)/18:1(9Z)/20:3(8Z,11Z,14Z))[iso6]259.6APOC2, LPL
15dodecylphosphocholine469.6APOE, APOC2
16TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]259.6LPL, APOC2
17thioflavin t469.6APOC2, APOE
18TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]259.6LPL, APOC2
19TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]259.5APOC2, LPL
20TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]259.5APOC2, LPL
21fenofibrate46 52 1211.5APOE, LPL, APOA5
22TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]259.5APOC2, LPL
23lovastatin46 52 62 30 1213.5LPL, APOA5, APOE
24TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]259.5APOC2, LPL
25atorvastatin46 52 30 25 1213.5APOE, APOA5, LPL
26TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]259.5APOC2, LPL
27simvastatin46 52 62 30 25 1214.5APOE, APOA5, LPL
28TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]259.5APOC2, LPL
29TG(18:2(9Z,12Z)/18:1(9Z)/20:2(11Z,14Z))[iso6]259.5APOC2, LPL
30TG(18:1(11Z)/14:0/18:1(9Z))[iso6]259.5LPL, APOC2
31TG(18:1(11Z)/14:0/18:1(11Z))[iso3]259.5APOC2, LPL
32TG(16:1(9Z)/14:0/18:1(11Z))[iso6]259.5APOC2, LPL
33TG(16:1(9Z)/14:0/16:1(9Z))[iso3]259.5APOC2, LPL
34TG(16:0/16:0/18:3(9Z,12Z,15Z))[iso3]259.4APOC2, LPL
35TG(15:0/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]259.4APOC2, LPL
36TG(15:0/18:2(9Z,12Z)/16:0)[iso6]259.4APOC2, LPL
37TG(15:0/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]259.4APOC2, LPL
38TG(18:1(9Z)/14:0/18:2(9Z,12Z))[iso6]259.3LPL, APOC2
39TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]259.3APOC2, LPL
40TG(18:1(9Z)/18:1(9Z)/20:3(8Z,11Z,14Z))[iso3]259.3APOC2, LPL
41TG(18:1(9Z)/18:1(9Z)/20:3(5Z,8Z,11Z))[iso3]259.2APOC2, LPL
42TG(18:1(9Z)/14:0/20:4(5Z,8Z,11Z,14Z))[iso6]259.2APOC2, LPL
43gemfibrozil30 46 1211.1LPL, APOE, APOC2
44sodium dodecylsulfate469.1LPL, APOC2, APOE
45TG(18:1(9Z)/18:1(9Z)/20:2(11Z,14Z))[iso3]259.1APOC2, LPL
46vitamin a46 25 1211.1LPL, APOC2, APOE
47TG(18:1(9Z)/16:0/18:3(9Z,12Z,15Z))[iso6]258.9APOC2, LPL
48triacylglycerol468.7LPL, APOE, APOA5, APOC2
49heparin46 30 25 1211.7APOA5, APOE, LPL, APOC2
50cholesterol46 30 25 1211.7APOC2, APOA5, APOE, LPL

GO Terms for genes affiliated with Hyperlipoproteinemia Type V

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Hyperlipoproteinemia Type V according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1intermediate-density lipoprotein particleGO:0343639.0APOC2, APOE
2high-density lipoprotein particleGO:0343648.9GPIHBP1, APOE, APOA5
3low-density lipoprotein particleGO:0343628.8APOC2, APOA5, APOE
4chylomicronGO:0426278.4LPL, APOC2, APOA5, APOE
5very-low-density lipoprotein particleGO:0343618.4APOE, APOA5, APOC2, LPL
6extracellular regionGO:0055768.3LPL, APOC2, APOA5, APOE
7extracellular spaceGO:0056158.0APOE, APOA5, APOC2, LPL

Biological processes related to Hyperlipoproteinemia Type V according to GeneCards/GeneDecks:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1triglyceride catabolic processGO:0194339.6LPL, APOA5
2positive regulation of very-low-density lipoprotein particle remodelingGO:0109029.5APOA5, APOC2
3triglyceride-rich lipoprotein particle remodelingGO:0343709.5APOA5, APOC2
4chylomicron remodelingGO:0343719.5APOC2, LPL
5lipid transportGO:0068699.4APOA5, GPIHBP1
6positive regulation of triglyceride catabolic processGO:0108989.4APOA5, APOC2
7positive regulation of fatty acid biosynthetic processGO:0457239.4APOC2, APOA5
8triglyceride metabolic processGO:0066419.4LPL, APOA5, APOE
9high-density lipoprotein particle clearanceGO:0343849.4APOE, APOC2
10chylomicron remnant clearanceGO:0343829.3APOE, APOC2
11phospholipid effluxGO:0337009.2APOE, APOC2
12reverse cholesterol transportGO:0436919.2APOC2, APOE
13cholesterol effluxGO:0333449.0APOE, APOC2
14very-low-density lipoprotein particle remodelingGO:0343729.0APOE, APOC2, LPL
15retinoid metabolic processGO:0015239.0LPL, APOC2, APOE
16positive regulation of lipoprotein lipase activityGO:0510068.9APOC2, APOA5, GPIHBP1
17phototransduction, visible lightGO:0076038.9LPL, APOC2, APOE
18lipoprotein metabolic processGO:0421578.6APOE, APOA5, APOC2, LPL
19triglyceride homeostasisGO:0703288.5LPL, APOC2, APOA5, GPIHBP1
20cholesterol homeostasisGO:0426328.4APOC2, APOA5, APOE, GPIHBP1
21small molecule metabolic processGO:0442818.0LPL, APOC2, APOA5, APOE

Molecular functions related to Hyperlipoproteinemia Type V according to GeneCards/GeneDecks:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1phospholipid bindingGO:0055439.5APOA5, APOE
2lipase bindingGO:0354739.4GPIHBP1, APOA5
3lipoprotein particle bindingGO:0718139.4GPIHBP1, APOE
4lipoprotein lipase activator activityGO:0602309.4APOC2, APOA5
5low-density lipoprotein particle receptor bindingGO:0507509.2APOA5, APOE
6heparin bindingGO:0082019.0LPL, APOA5, APOE
7lipid bindingGO:0082898.2APOC2, APOA5, APOE, GPIHBP1

Products for genes affiliated with Hyperlipoproteinemia Type V

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Hyperlipoproteinemia Type V

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet